Mobile coaching may help dialysis patients shed excess fluid
NCT ID NCT07677605
First seen Jul 01, 2026 · Last updated Jul 01, 2026
Summary
This trial tests a self-management program that uses education, WhatsApp reminders, and a diary to help hemodialysis patients control weight gain between sessions. The program aims to improve fluid adherence and stabilize blood pressure. Participants are adults on maintenance hemodialysis who own a smartphone and use WhatsApp.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Theory-based fluid self-management program
What this could lead to
If effective, this program could offer a simple, low-cost way for dialysis patients to better manage fluid intake and improve health outcomes.
What could go wrong
This is a behavioral intervention, not a drug, so results depend on patient engagement. The study is relatively small and may not apply to all dialysis patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dr. Soeradji Tirtonegoro General Hospital l. Dr. Soeradji Tirtonegoro No.1, Dusun 1, Tegalyoso
Klaten, Central Java, 57424, Indonesia
Contact Phone: •••-•••-•••• Email: •••••@•••••